The IVD Raw Materials Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for IVD raw materials has experienced substantial growth recently. In 2024, it was valued at $25.13 billion and is expected to reach $27.73 billion in 2025, representing a compound annual growth rate (CAGR) of 10.3%.
The IVD raw materials global market is forecasted to reach $40.74 billion in 2029, with a compound annual growth rate (CAGR) of 10.1%.
Download Your Free Sample of the 2025 IVD Raw Materials Market Report and Uncover Key Trends Now!The key drivers in the ivd raw materials market are:
• Rising demand for rapid and highly sensitive diagnostic solutions
• Expanding use of molecular diagnostics specifically in the field of oncology
• Increasing burden of diseases related to the growing geriatric population
• Elevated demand for companion diagnostics and increased investments by biopharmaceutical companies.
The IVD raw materials market covered in this report is segmented –
1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers, Other Products
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Other Technologies
3) By End User: Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Other End Users
The key trends in the ivd raw materials market are:
• The market is transitioning towards the usage of recombinant and synthetic raw materials.
• The integration of multiplex assays which require specialized materials is an emerging trend.
• There is a rising trend of adopting lyophilized and ready-to-use reagent formats.
• The development of raw materials specialized for microfluidic and lab-on-a-chip systems is shaping the market's future.
Major players in the ivd raw materials market are:
• F. Hoffmann-La Roche
• Merck KGaA
• Thermo Fisher Scientific
• Abbott Laboratories
• Siemens Healthineers
• Becton Dickinson and Company (BD)
• Agilent Technologies
• Sysmex Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• LGC Limited
• Neogen Corporation
• MP Biomedicals
• CUSABIO Technology
• Fujirebio
• Fapon Biotech
• ABclonal Technology
• Creative Diagnostics
• AIVD Biotech Inc.
• OPERON
• Beijing Diagreat Biotechnology Co. Ltd.
• Biosynth
• Aalto Bio Reagents
• Angstrom Biotech
• Eximio Biotech
• Glentham Life Sciences Limited
• OYC Americas Inc.
• NOVA Biologics Inc.
North America was the largest region in the IVD raw materials market in 2024